506879 — Gujarat Themis Biosyn Income Statement

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapHigh Flyer

Annual income statement for Gujarat Themis Biosyn, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	1,149	1,490	1,698	1,508	1,658
Cost of Revenue
Gross Profit	982	918	1,017	923	1,064
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Other Operating Expenses
Total Operating Expenses	590	773	946	872	1,032
Operating Profit	558	716	752	636	626
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	590	775	793	655	621
Provision for Income Taxes
Net Income After Taxes	436	580	592	488	467
Net Income Before Extraordinary Items
Net Income	436	580	592	488	467
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	436	580	592	488	467
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4	5.32	5.43	4.47	4.28
Dividends per Share